gvtcx

PS25204 - UKSAC25_0057 - ESA Strategic Study (Phases 3 and 4)

UK Space Agency Published 8 Oct 2025 Find a Tender

key details

Value£41,660 (£50,000 inc. VAT)
Statuscomplete
Category (CPV) 73000000
Deadline15 Sept 2025
Procedureopen
SME suitableYes
OCIDocds-h6vhtk-058d92

Award

SupplierValueDateStatus
KNOW. CONSULTING LIMITED · · active

description

Overall Aim

Expand the scope of the ESA Strategic Study to encompass additional ESA Member States and key developments in the European space sector, to both support preparations for the upcoming ESA Council of Ministers 2025 (CM25) meeting and supplement the institutional knowledge of the UK Space Agency more broadly.

Objectives

  • Analyse key developments in the European space sector, specifically narratives underpinning space policy formulation in the European Union (at institutional level), and the interaction between civil, military and dual use approaches to space activities employed by the ESA Member States covered under Phase 1 and 2 (Germany, France, Italy, Switzerland and Norway), as well as Spain, Belgium, Poland, and the European Union (EU).
  • Deliver accessible insights in time for ESA’s Council of Ministers 2025 (CM25) meeting on 26-27 November 2025 (Phase 3).
  • Deliver detailed analyses of the narratives underpinning space policy formulation in Spain, Belgium, Poland, and the European Union for use by UK Space Agency teams in the short-, medium-, and long- term.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
26 Aug 2025 Tender notice (UK4) Procurement Act 2023 051179-2025
8 Oct 2025 Contract details (UK7) Procurement Act 2023 063172-2025

more from UK Space Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.